Tafamidis treatment in patients with transthyretin amyloid cardiomyopathy: a systematic review and meta-analysis

EClinicalMedicine(2023)

Cited 0|Views19
No score
Abstract
This work was supported by grants from the Natural Science Foundation of Sichuan Province [Grant Number: 23NSFSC4589] and the National Natural Science Foundation of China [Grant Number: 82202248].
More
Translated text
Key words
Tafamidis,Transthyretin amyloid cardiomyopathy,ATTR,Prognosis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined